| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 05/20/2004 | US20040097503 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/20/2004 | US20040097502 For therapy and prophylaxis of disorders characterised by overexpression of transforming growth factor |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097497 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 05/20/2004 | US20040097496 Novel thiazine derivatives |
| 05/20/2004 | US20040097492 For inhibiting hepatitis C virus (HCV) polymerase; therapy and prophylaxis of HCV infection |
| 05/20/2004 | US20040097491 For use as antithrombotic agents |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097483 Benzimidazole derivatives useful as histamine H3 antagonists |
| 05/20/2004 | US20040097471 For therapy and prophylaxis of influenza infection |
| 05/20/2004 | US20040097438 Fused-ring compounds and use thereof as drugs |
| 05/20/2004 | US20040096787 Color photography |
| 05/20/2004 | US20040093676 Chromatic direct dyes |
| 05/19/2004 | EP1419152A1 Hiv inhibiting pyrimidines derivatives |
| 05/19/2004 | EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 05/19/2004 | EP1419149A1 Benzo g] quinoline derivatives for treating glaucoma and myopia |
| 05/19/2004 | EP1419125A1 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids |
| 05/19/2004 | EP1418913A1 Substituted urea neuropeptide y y5 receptor antagonists |
| 05/19/2004 | EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 05/19/2004 | EP1273575B1 Diazepane derivatives or salts thereof |
| 05/19/2004 | EP1259505B1 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same |
| 05/19/2004 | EP1147084B1 Phenylsulphonyl derivatives as 5-ht receptor ligands |
| 05/19/2004 | EP1131308B1 New piperazine and piperidine compounds |
| 05/19/2004 | EP1086097B1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1020453B1 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP0947513B1 Tricyclic amine derivatives |
| 05/19/2004 | EP0722936B1 Fused pyridazine compound |
| 05/19/2004 | EP0717736B1 Phosphorus derivatives to treat aids |
| 05/19/2004 | DE10251019A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
| 05/19/2004 | DE10250708A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them |
| 05/19/2004 | CN1498245A Highly nucleated thermoplastic articles |
| 05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
| 05/19/2004 | CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 05/19/2004 | CN1498211A Aniline derivative using as phosphodiesterase 4 inhibitor |
| 05/19/2004 | CN1498210A MCH antagonists and their use in treatment of obesity |
| 05/19/2004 | CN1498206A Biurethane derivatives |
| 05/19/2004 | CN1497006A Preparation method of poly (diimide ether) |
| 05/19/2004 | CN1496982A Imidazoline compound, its preparation method and drug composition containing them |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1496980A N-substituted indole-3-acetaldehyde amide compound with anti-asthma, anti-amaphylactic and immunosupression/immunoregulation action |
| 05/19/2004 | CN1150192C Piperidines as CCR5 modulators |
| 05/19/2004 | CN1150186C 苯并咪唑化合物结晶 Benzimidazole compound crystallized |
| 05/19/2004 | CN1150185C Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositiions contg. said compounds and use thereof |
| 05/19/2004 | CN1150184C Production method of imidacloprid |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150171C Bicyclic heterocycles, pharmaceutical compositions containing these compounds,and processes for preparing them |
| 05/19/2004 | CN1150165C 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivativer for treatment of CNS disorders |
| 05/19/2004 | CN1149995C Use of quinazolonone-containing compositions in pharmaceutical |
| 05/18/2004 | US6737435 Indole derivatives and their use as MCP-1 antagonist |
| 05/18/2004 | US6737430 Mutual prodrug of amlodipine and atorvastatin |
| 05/18/2004 | US6737429 Pyrrole derivatives |
| 05/18/2004 | US6737425 N,N-substituted cyclic amine derivatives |
| 05/18/2004 | US6737422 Voltage-dependent |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6736862 Indole/indoline based hybrid dyes and indole/indoline based hybrid dye intermediate products |
| 05/18/2004 | CA2334317C Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 05/18/2004 | CA2297279C New cyano-indole compounds that inhibit serotonin recapture, the process for their preparation and the pharmaceutical compounds that contain them |
| 05/18/2004 | CA2225746C 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 05/18/2004 | CA2214759C Intimal hypertrophy inhibitors |
| 05/13/2004 | WO2004039934A1 Use of metal complex compounds as oxidation catalysts |
| 05/13/2004 | WO2004039796A1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 05/13/2004 | WO2004039795A2 Amide compounds for the treatment of hyperlipidemia |
| 05/13/2004 | WO2004039784A1 Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists |
| 05/13/2004 | WO2004039782A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME |
| 05/13/2004 | WO2004039780A1 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 05/13/2004 | WO2004039774A2 Mitotic kinesin inhibitors |
| 05/13/2004 | WO2004039374A1 Quaternary ammonium compounds as muscarinic receptor antagonists |
| 05/13/2004 | WO2004039370A1 Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors |
| 05/13/2004 | WO2004039367A1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 05/13/2004 | WO2004039365A1 Agent for preventing or treating neuropathy |
| 05/13/2004 | WO2004039318A2 Anti-infective biaryl compounds |
| 05/13/2004 | WO2004026305A9 Diaryl ethers as opioid receptor antagonist |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | WO2004020431A3 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 05/13/2004 | WO2003079986A3 Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases |
| 05/13/2004 | WO2002072578A3 (homo) piperazine substituted quinolines for inhibiting the phosphorylation of kinases |
| 05/13/2004 | WO2002055013A8 Therapeutic chromone compounds |
| 05/13/2004 | US20040092747 Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 05/13/2004 | US20040092746 Fungicides |
| 05/13/2004 | US20040092745 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092740 Hyperpermeability; diabetic retinopathy, ischemic retinal-vein occlusion, prematurity, age-related macular degeneration |
| 05/13/2004 | US20040092687 Polymeric charge transport compositions and electronic devices made with such compositions |
| 05/13/2004 | US20040092628 Heat and oxidation resistance; photostability; for automobile coatings, candle wax |
| 05/13/2004 | US20040092604 Amino-tetralin derivatives as muscarinic receptor antagonists |
| 05/13/2004 | US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 05/13/2004 | US20040092567 Cardiovascular disorders; hypotensive agents |
| 05/13/2004 | US20040092563 Angiotensin II antagonists |
| 05/13/2004 | US20040092556 Aids therapy |
| 05/13/2004 | US20040092554 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists |
| 05/13/2004 | US20040092551 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092546 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| 05/13/2004 | US20040092535 Anticancer agents; antidiabetic agents; Alzheimer's disease; autoimmune disease |
| 05/13/2004 | US20040092526 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092524 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same |
| 05/13/2004 | US20040092521 Antihistamines; central nervous system disorders |
| 05/13/2004 | US20040092514 Novel tyrosine kinase inhibitors |
| 05/13/2004 | US20040092513 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 05/13/2004 | US20040092508 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |